Summary
86 / 100 · Bulios Score
What speaks for it
- Out of every 100 IDR of revenue, 34 IDR is left as net profit.
- Revenue grew by 23% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
- Analysts expect revenue to fall by 29% this fiscal year.
- 94% of profit goes to the dividend, leaving little room to raise it.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 5.8 IDR for 1 IDR of yearly profit. Over the last five years it was 10.5 IDR on average.
Valuation in detailIs it growing?
Yes, fastRevenue (IDR)
Diluted EPS (IDR)
- Analyst estimate
Revenue grew by 12% a year over 5 years. Over the last 3 years it grew by 23% a year. For the next fiscal year analysts expect revenue to fall by 29%.
Growth in detailDoes it make money?
Very wellWhere 100 IDR of revenue goes
- Cost of sales 22 IDR
- Sales and administration 44 IDR
- Taxes and other 12 IDR
- Net profit 34 IDR
Net profit, industry median (Banks - Regional) 21 IDR
Out of every 100 IDR of revenue, 34 IDR is left as net profit.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 16.17%
- Paid out of profit
- 94%
- Raised in a row
- 1 year
You receive $0.03 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.